InvestorsHub Logo
icon url

Biobillionair

10/10/20 12:26 PM

#304292 RE: sstyles #304291

It's directly on Marksman page. BB


We have consulted on patent issues related to the following pharmaceutical drugs and related technologies:

Vascepa® (Amarin, $AMRN)



https://www.markmanadvisors.com/consulting

I believe Amarin/Marksman failed to connect 'motive' of table cropping in Kurabayashi...and this is why it wasn't argued. Our Amicus dug into Heinecke and shows the motivation behind the cropping of table and legend.

Notice how the Marksman leaves out Heinecke testimony.....It was a big moment in developing our argument after finding Heinecke impeach himself regarding Kurabayashi LDL. It's reasonable to assume this was just missed by Amarin attorney that where just too focused on secondary crap.

BB